{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:55:28Z","timestamp":1777215328984,"version":"3.51.4"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2009,4,14]],"date-time":"2009-04-14T00:00:00Z","timestamp":1239667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0005209","type":"journal-article","created":{"date-parts":[[2009,4,13]],"date-time":"2009-04-13T22:48:26Z","timestamp":1239662906000},"page":"e5209","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":101,"title":["Molecular and Phenotypic Characterisation of Paediatric Glioma Cell Lines as Models for Preclinical Drug Development"],"prefix":"10.1371","volume":"4","author":[{"given":"Dorine A.","family":"Bax","sequence":"first","affiliation":[]},{"given":"Suzanne E.","family":"Little","sequence":"additional","affiliation":[]},{"given":"Nathalie","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Lara","family":"Perryman","sequence":"additional","affiliation":[]},{"given":"Lynley","family":"Marshall","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Viana-Pereira","sequence":"additional","affiliation":[]},{"given":"Tania A.","family":"Jones","sequence":"additional","affiliation":[]},{"given":"Richard D.","family":"Williams","sequence":"additional","affiliation":[]},{"given":"Anita","family":"Grigoriadis","sequence":"additional","affiliation":[]},{"given":"Gilles","family":"Vassal","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Workman","sequence":"additional","affiliation":[]},{"given":"Denise","family":"Sheer","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Andrew D. J.","family":"Pearson","sequence":"additional","affiliation":[]},{"given":"Darren","family":"Hargrave","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,4,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11910-001-0009-7","article-title":"Advances in biology and treatment of childhood brain tumors.","volume":"1","author":"AT Reddy","year":"2001","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1215\/15228517-2006-036","article-title":"Molecular pathogenesis of pediatric astrocytic tumors.","volume":"9","author":"M Nakamura","year":"2007","journal-title":"Neuro Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1200\/JCO.2006.06.8213","article-title":"Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.","volume":"25","author":"A Broniscer","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1477::AID-CNCR28>3.0.CO;2-8","article-title":"Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium.","volume":"88","author":"FH Gilles","year":"2000","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma.","volume":"352","author":"ME Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2006.05.7265","article-title":"O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.","volume":"24","author":"IF Pollack","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-005-7409-5","article-title":"Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.","volume":"76","author":"A Broniscer","year":"2006","journal-title":"J Neurooncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/cncr.22961","article-title":"Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children&apos;s Oncology Group.","volume":"110","author":"HS Nicholson","year":"2007","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-005-9011-2","article-title":"Phase II trial of temozolomide in children with recurrent high-grade glioma.","volume":"77","author":"A Ruggiero","year":"2006","journal-title":"J Neurooncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1586\/14737175.7.8.1029","article-title":"Pediatric CNS tumors: current treatment and future directions.","volume":"7","author":"DR Hargrave","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/JCO.2004.08.110","article-title":"Phase II trial of gefitinib in recurrent glioblastoma.","volume":"22","author":"JN Rich","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1158\/1078-0432.CCR-06-0773","article-title":"Phase I\/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.","volume":"12","author":"PY Wen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng1201-365","article-title":"Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.","volume":"29","author":"A Brazma","year":"2001","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000015092","article-title":"An optimized, fully automated system for fast and accurate identification of chromosomal rearrangements by multiplex-FISH (M-FISH).","volume":"82","author":"R Eils","year":"1998","journal-title":"Cytogenet Cell Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/labinvest.3700390","article-title":"Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.","volume":"86","author":"MB Lambros","year":"2006","journal-title":"Lab Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1093\/nar\/gni127","article-title":"Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences.","volume":"33","author":"AO Nygren","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/labinvest.3700664","article-title":"MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas.","volume":"87","author":"JW Jeuken","year":"2007","journal-title":"Lab Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/1078-0432.CCR-04-2045","article-title":"O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.","volume":"11","author":"MS Bobola","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0046-8177(99)90057-6","article-title":"Genetic alterations in pediatric high-grade astrocytomas.","volume":"30","author":"Y Cheng","year":"1999","journal-title":"Hum Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/JCO.2006.07.8626","article-title":"Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.","volume":"25","author":"D Faury","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0002-9440(10)64103-X","article-title":"Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases.","volume":"158","author":"CH Rickert","year":"2001","journal-title":"Am J Pathol"},{"key":"ref23","first-page":"2987","article-title":"Oncogene amplification in pediatric brain tumors.","volume":"50","author":"JC Wasson","year":"1990","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1158\/0008-5472.CAN-06-2438","article-title":"Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.","volume":"66","author":"KK Wong","year":"2006","journal-title":"Cancer Res"},{"key":"ref25","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways.","author":"R McLendon","year":"2008","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme.","volume":"321","author":"DW Parsons","year":"2008","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1242\/jcs.010389","article-title":"The RASSF1A tumor suppressor.","volume":"120","author":"H Donninger","year":"2007","journal-title":"J Cell Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9440(10)63376-7","article-title":"Aberrant methylation and down-regulation of TMS1\/ASC in human glioblastoma.","volume":"165","author":"AR Stone","year":"2004","journal-title":"Am J Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1158\/1078-0432.CCR-05-1830","article-title":"In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.","volume":"12","author":"JP Fruehauf","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref30","article-title":"Differential mechanisms of temozolomide resistance in paediatric glioma cell lines.","author":"N Gaspar"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/NEN.0b013e3181845622","article-title":"Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.","volume":"67","author":"EE Bar","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1593\/neo.07914","article-title":"Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.","volume":"10","author":"N Potter","year":"2008","journal-title":"Neoplasia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cancergencyto.2003.12.017","article-title":"Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas.","volume":"153","author":"W Krupp","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1936","DOI":"10.1371\/journal.pone.0001936","article-title":"Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.","volume":"3","author":"J Rebetz","year":"2008","journal-title":"PLoS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1371\/journal.pmed.0050008","article-title":"Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.","volume":"5","author":"TF Cloughesy","year":"2008","journal-title":"PLoS Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.bjc.6603586","article-title":"Interleukin-6 gene amplification and shortened survival in glioblastoma patients.","volume":"96","author":"A Tchirkov","year":"2007","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/138161206775201901","article-title":"Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.","volume":"12","author":"W Wick","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2007.06.005","article-title":"Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma.","volume":"15","author":"JF Parkinson","year":"2008","journal-title":"J Clin Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ctrv.2008.03.125","article-title":"DNA repair and cancer stem-like cells - Potential partners in glioma drug resistance?","volume":"34","author":"TC Johannessen","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/1541-7786.MCR-07-2180","article-title":"Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas.","volume":"6","author":"EC Brantley","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/0008-5472.CAN-08-3131","article-title":"Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cell lines.","volume":"69","author":"N Gaspar","year":"2009","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0006-2952(02)00876-6","article-title":"Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.","volume":"63","author":"J Ma","year":"2002","journal-title":"Biochem Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0005209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:15:27Z","timestamp":1540340127000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0005209"}},"subtitle":[],"editor":[{"given":"Mikhail V.","family":"Blagosklonny","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,4,14]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0005209","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,14]]}}}